A patient-controlled registry allows imaging data to be shared without placing undue burdens on the patients, providers or infrastructures.
Use of a patient-controlled access registry allows imaging data to be shared between unaffiliated health care facilities without placing undue burdens on the patients, providers or infrastructures, said researchers in an article published by the Journal of the American Informatics Association.
Researchers from Wake Forest School of Medicine in Winston-Salem, N.C., built a patient-controlled access-key registry (PCARE), which allowed participating patients to electronically verify their identities. The goal was to avoid having patients hand-deliver images or CDs, or burdensome requests to be sent between institutions.
Through the PCARE portal, access keys were issued by the image source facilities and when the keys were digitally signed by the patients for requesting facilities, the images became available for retrieval. In addition to ease of information transfer, this type of system would help protect patient privacy, the authors said.
“The same framework can also be used to realize a longitudinal virtual electronic health record,” the authors wrote.
A prototype has been implemented to demonstrate the feasibility of such a framework, as well as the benefits of the approach.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.